Synonym
Seganserin; Seganserinum; Seganserine
IUPAC/Chemical Name
3-(2-(4-(Bis(p-fluorophenyl)methylene)piperidino)ethyl)-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
InChi Key
ZGUPMFYFHHSNFK-UHFFFAOYSA-N
InChi Code
InChI=1S/C29H27F2N3O/c1-20-26(29(35)34-16-3-2-4-27(34)32-20)15-19-33-17-13-23(14-18-33)28(21-5-9-24(30)10-6-21)22-7-11-25(31)12-8-22/h2-12,16H,13-15,17-19H2,1H3
SMILES Code
O=C1C(CCN2CC/C(CC2)=C(C3=CC=C(F)C=C3)\C4=CC=C(F)C=C4)=C(C)N=C5N1C=CC=C5
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
471.55
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Dijk DJ, Beersma DG, Daan S, van den Hoofdakker RH. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol. 1989 Nov 21;171(2-3):207-18. PubMed PMID: 2576000.
2: Monti JM. Serotonin 5-HT(2A) receptor antagonists in the treatment of insomnia: present status and future prospects. Drugs Today (Barc). 2010 Mar;46(3):183-93. doi: 10.1358/dot.2010.46.3.1437247. Review. PubMed PMID: 20467592.
3: Kaur G, Kulkarni SK. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. Brain Res. 2002 Jul 12;943(2):206-15. PubMed PMID: 12101043.
4: Kaur G, Kulkarni SK. Investigations on possible serotonergic involvement in effects of OB-200G (polyherbal preparation) on food intake in female mice. Eur J Nutr. 2001 Jun;40(3):127-33. PubMed PMID: 11697445.
5: Ninan I, Kulkarni SK. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur J Pharmacol. 1998 Oct 2;358(2):111-6. PubMed PMID: 9808259.
6: Naidu PS, Kulkarni SK. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements. Eur J Pharmacol. 2001 Sep 28;428(1):81-6. PubMed PMID: 11779040.
7: Yurdaydin C, Herneth AM, Püspök A, Steindl P, Singer E, Ferenci P. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists. Eur J Gastroenterol Hepatol. 1996 Jul;8(7):667-71. PubMed PMID: 8853256.
8: Seifritz E, Moore P, Trachsel L, Bhatti T, Stahl SM, Gillin JC. The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci Lett. 1996 May 3;209(1):41-4. PubMed PMID: 8734905.
9: Critchley MA, Handley SL. Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology (Berl). 1987;93(4):502-6. PubMed PMID: 3124184.
10: Korstanje C, Sprenkels R, Doods HN, Hugtenburg JG, Boddeke E, Batink HD, Thoolen MJ, Van Zwieten PA. Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in-vivo alpha 1-,alpha 2- and 5-HT2-receptor antagonism and in-vitro affinity for alpha 1-,alpha 2- and 5-HT2-receptors: comparison with ketanserin. J Pharm Pharmacol. 1986 May;38(5):374-9. PubMed PMID: 2872314.
11: Pettersson A, Gradin K, Hedner T, Persson B. Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):394-7. PubMed PMID: 2993926.
12: Colpaert FC, Meert TF, Niemegeers CJ, Janssen PA. Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat. Psychopharmacology (Berl). 1985;86(1-2):45-54. PubMed PMID: 2862659.
13: Skolnik G, Bagge U, Blomqvist G, Djärv L, Ahlman H. The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver. Clin Exp Metastasis. 1989 Mar-Apr;7(2):169-74. PubMed PMID: 2537694.
